Showing 1 - 14 results of 14 for search 'David Hsiehchen', query time: 4.47s Refine Results
  1. 1
    The Cooperative Landscape of Multinational Clinical Trials.

    The Cooperative Landscape of Multinational Clinical Trials. by David Hsiehchen, Magdalena Espinoza, Antony Hsieh

    Published 2015-01-01
    Get full text
    Article
  2. 2
    Female dermatology journal editors accepting pharmaceutical payments: An analysis of the Open Payments database, 2013 to 2018

    Female dermatology journal editors accepting pharmaceutical payments: An analysis of the Open Payments database, 2013 to 2018 by Waqas Haque, MPH, MPhil, Eman Haque, David Hsiehchen, MD

    Published 2021-09-01
    Get full text
    Article
  3. 3
    Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancers

    Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancers by David Hsiehchen, Leslie Bucheit, Dong Yang, Muhammad Shaalan Beg, Mir Lim, Sunyoung S. Lee, Pashtoon Murtaza Kasi, Ahmed O. Kaseb, Hao Zhu

    Published 2022-12-01
    Get full text
    Article
  4. 4
    DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation Burden

    DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation Burden by David Hsiehchen, Antony Hsieh, Robert M. Samstein, Tianshi Lu, Muhammad S. Beg, David E. Gerber, Tao Wang, Luc G.T. Morris, Hao Zhu

    Published 2020-06-01
    Get full text
    Article
  5. 5
    Author Correction: Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancers

    Author Correction: Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancers by David Hsiehchen, Leslie Bucheit, Dong Yang, Muhammad Shaalan Beg, Mir Lim, Sunyoung S. Lee, Pashtoon Murtaza Kasi, Ahmed O. Kaseb, Hao Zhu

    Published 2023-11-01
    Get full text
    Article
  6. 6
    Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors

    Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors by Krista Y. Chen, Aleksandra Popovic, David Hsiehchen, Marina Baretti, Paige Griffith, Ranjan Bista, Azarakhsh Baghdadi, Ihab R. Kamel, Sanford M. Simon, Rachael D. Migler, Mark Yarchoan

    Published 2022-10-01
    Get full text
    Article
  7. 7
    T-cell tolerant fraction as a predictor of immune-related adverse events

    T-cell tolerant fraction as a predictor of immune-related adverse events by Yang Xie, Shaheen Khan, Prithvi Raj, Edward K Wakeland, Mitchell S von Itzstein, Farjana Fattah, Jason Y Park, David Hsiehchen, Jared Ostmeyer, David E Gerber, Mary Gwin, Rodrigo Catalan

    Published 2023-08-01
    Get full text
    Article
  8. 8
    Characteristics and clinical outcomes in young‐onset cholangiocarcinoma

    Characteristics and clinical outcomes in young‐onset cholangiocarcinoma by Sarah Reddy, Suleyman Yasin Goksu, Nina N. Sanford, Radhika Kainthla, David Hsiehchen, Aravind Sanjeevaiah, Amy L. Jones, Georgios Karagkounis, Salwan Al Mutar, Chul Ahn, Muhammad S. Beg, Syed M. Kazmi

    Published 2023-07-01
    Get full text
    Article
  9. 9
    Distinct Clinical Characteristics in Young-Onset Pancreatic Neuroendocrine Tumor

    Distinct Clinical Characteristics in Young-Onset Pancreatic Neuroendocrine Tumor by Suleyman Yasin Goksu, Muhammet Ozer, Syed Mohammad Ali Kazmi, Nina Niu Sanford, Todd A. Aguilera, Chul Ahn, David Hsiehchen, Aravind Sanjeevaiah, Leticia Khosama, Jonathan Bleeker, Muslim Atiq, Muhammad Shaalan Beg

    Published 2020-09-01
    Get full text
    Article
  10. 10
    Racial/Ethnic Disparities and Survival Characteristics in Non-Pancreatic Gastrointestinal Tract Neuroendocrine Tumors

    Racial/Ethnic Disparities and Survival Characteristics in Non-Pancreatic Gastrointestinal Tract Neuroendocrine Tumors by Suleyman Yasin Goksu, Muhammet Ozer, Muhammad S. Beg, Nina Niu Sanford, Chul Ahn, Benjamin D. Fangman, Busra B. Goksu, Udit Verma, Aravind Sanjeevaiah, David Hsiehchen, Amy L. Jones, Radhika Kainthla, Syed M. Kazmi

    Published 2020-10-01
    Get full text
    Article
  11. 11
    Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy

    Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy by Mitchell S. von Itzstein, Amrit S. Gonugunta, Thomas Sheffield, Jade Homsi, Jonathan E. Dowell, Andrew Y. Koh, Prithvi Raj, Farjana Fattah, Yiqing Wang, Vijay S. Basava, Shaheen Khan, Jason Y. Park, Vinita Popat, Jessica M. Saltarski, Yvonne Gloria-McCutchen, David Hsiehchen, Jared Ostmeyer, Yang Xie, Quan-Zhen Li, Edward K. Wakeland, David E. Gerber

    Published 2022-03-01
    Get full text
    Article
  12. 12
    The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial

    The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial by David Hsiehchen, Muhammad S. Beg, Radhika Kainthla, Jay Lohrey, Syed M. Kazmi, Leticia Khosama, Mary Claire Maxwell, Heather Kline, Courtney Katz, Asim Hassan, Naoto Kubota, Ellen Siglinsky, Anil K. Pillai, Hagop Youssoufian, Colleen Mockbee, Kerry Culm, Mark Uhlik, Laura Benjamin, Rolf A. Brekken, Chul Ahn, Amit G. Singal, Hao Zhu, Yujin Hoshida, Adam C. Yopp

    Published 2024-03-01
    Get full text
    Article
  13. 13
    Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice

    Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice by Mitchell S. von Itzstein, Mitchell S. von Itzstein, Yuqiu Yang, Yiqing Wang, David Hsiehchen, Thomas Y. Sheffield, Farjana Fattah, Vinita Popat, Murtaza Ahmed, Jade Homsi, Jade Homsi, Jonathan E. Dowell, Jonathan E. Dowell, Sawsan Rashdan, Sawsan Rashdan, Jay Lohrey, Jay Lohrey, Hans J. Hammers, Hans J. Hammers, Randall S. Hughes, Randall S. Hughes, Tao Wang, Tao Wang, Yang Xie, Yang Xie, David E. Gerber, David E. Gerber, David E. Gerber

    Published 2024-04-01
    Get full text
    Article
  14. 14
    PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system

    PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system by Kai Zimmer, Florian Kocher, Gerold Untergasser, Brigitte Kircher, Arno Amann, Yasmine Baca, Joanne Xiu, W. Micheal Korn, Martin D. Berger, Heinz-Josef Lenz, Alberto Puccini, Elisa Fontana, Anthony F. Shields, John L. Marshall, Michael Hall, Wafik S. El-Deiry, David Hsiehchen, Teresa Macarulla, Josep Tabernero, Renate Pichler, Moh’d Khushman, Upender Manne, Emil Lou, Dominik Wolf, Viktorija Sokolova, Simon Schnaiter, Alain G. Zeimet, Pat Gulhati, Gerlig Widmann, Andreas Seeber

    Published 2023-07-01
    Get full text
    Article

Search Tools: